These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 14519438)

  • 1. Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an alpha-tropomyosin mutation linked to familial hypertrophic cardiomyopathy.
    Burkart EM; Arteaga GM; Sumandea MP; Prabhakar R; Wieczorek DF; Solaro RJ
    J Mol Cell Cardiol; 2003 Oct; 35(10):1285-93. PubMed ID: 14519438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of protein kinase C dependent phosphorylation and a familial hypertrophic cardiomyopathy-related mutation of cardiac troponin I on structural transition of troponin C and myofilament activation.
    Kobayashi T; Dong WJ; Burkart EM; Cheung HC; Solaro RJ
    Biochemistry; 2004 May; 43(20):5996-6004. PubMed ID: 15147183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity.
    Burkart EM; Sumandea MP; Kobayashi T; Nili M; Martin AF; Homsher E; Solaro RJ
    J Biol Chem; 2003 Mar; 278(13):11265-72. PubMed ID: 12551921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions at the NH2-terminal interface of cardiac troponin I modulate myofilament activation.
    Rarick HM; Tang HP; Guo XD; Martin AF; Solaro RJ
    J Mol Cell Cardiol; 1999 Feb; 31(2):363-75. PubMed ID: 10093049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.
    Takahashi-Yanaga F; Morimoto S; Harada K; Minakami R; Shiraishi F; Ohta M; Lu QW; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2001 Dec; 33(12):2095-107. PubMed ID: 11735257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosis.
    Sheehan KA; Arteaga GM; Hinken AC; Dias FA; Ribeiro C; Wieczorek DF; Solaro RJ; Wolska BM
    J Mol Cell Cardiol; 2011 Mar; 50(3):442-50. PubMed ID: 21047515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T.
    Chandra M; Rundell VL; Tardiff JC; Leinwand LA; De Tombe PP; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H705-13. PubMed ID: 11158969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cardiac troponin C with Ca(2+) sensitizer EMD 57033 and cardiac troponin I inhibitory peptide.
    Li MX; Spyracopoulos L; Beier N; Putkey JA; Sykes BD
    Biochemistry; 2000 Aug; 39(30):8782-90. PubMed ID: 10913289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
    Parvatiyar MS; Pinto JR
    Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C.
    Li MX; Wang X; Lindhout DA; Buscemi N; Van Eyk JE; Sykes BD
    Biochemistry; 2003 Dec; 42(49):14460-8. PubMed ID: 14661957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation.
    Biesiadecki BJ; Kobayashi T; Walker JS; Solaro RJ; de Tombe PP
    Circ Res; 2007 May; 100(10):1486-93. PubMed ID: 17446435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy.
    Evans CC; Pena JR; Phillips RM; Muthuchamy M; Wieczorek DF; Solaro RJ; Wolska BM
    Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2414-23. PubMed ID: 11045979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
    Gaffin RD; Peña JR; Alves MS; Dias FA; Chowdhury SA; Heinrich LS; Goldspink PH; Kranias EG; Wieczorek DF; Wolska BM
    J Mol Cell Cardiol; 2011 Nov; 51(5):812-20. PubMed ID: 21840315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force.
    Montgomery DE; Chandra M; Huang Q; Jin J; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1011-8. PubMed ID: 11179042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy.
    Wilder T; Ryba DM; Wieczorek DF; Wolska BM; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1720-30. PubMed ID: 26432840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I.
    Arteaga GM; Palmiter KA; Leiden JM; Solaro RJ
    J Physiol; 2000 Aug; 526 Pt 3(Pt 3):541-9. PubMed ID: 10922006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tropomyosin-κ induces dilated cardiomyopathy and depresses cardiac myofilament tension by mechanisms involving cross-bridge dependent activation and altered tropomyosin phosphorylation.
    Karam CN; Warren CM; Rajan S; de Tombe PP; Wieczorek DF; Solaro RJ
    J Muscle Res Cell Motil; 2011 Mar; 31(5-6):315-22. PubMed ID: 21221740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C.
    Lindhout DA; Li MX; Schieve D; Sykes BD
    Biochemistry; 2002 Jun; 41(23):7267-74. PubMed ID: 12044157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of regions of troponin I important in deactivation of cardiac myofilaments by acidic pH.
    Li G; Martin AF; Solaro RJ
    J Mol Cell Cardiol; 2001 Jul; 33(7):1309-20. PubMed ID: 11437537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.